Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1995-09-19
1997-05-27
Azpuru, Carlos A.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
5147723, 514777, A61F 202, A61K 4730
Patent
active
056330014
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
The present invention relates to a composition and a method for tissue augmentation.
Tissue augmentation is desirable for both therapeutical and cosmetical purposes. A therapeutical application is, for example, augmentation of tissues that need to be enlarged for proper function. Examples of such are the vocal cords, the oesophagus, various sphinters that have become weakened or have too thin tissue mass. Another set of examples are enlargement of the muscles of, for instance, the urether and rectum. In the field of cosmetic surgery tissue augmentation is applied to wrinkles and scars as well as to enlarge lips or fill out age related diminished fat deposits around the eyes as well as other applications. In the cosmetical field, plastic surgeons fill out, for example, eye wrinkles, by injecting tissue augmenting materials.
Materials used for augmentation of tissues are, for instance, the patients own fat cell cartilage or other suitable materials. Commercially available biologically degradable materials include collagen suspensions and crosslinked hyaluronic acid. Non degradable materials include silicone oil, silicone microparticles, Teflon.RTM. paste and other inert materials.
U.S. Pat. No. 5,007,940 teaches the use of deformable, nonbiodegradable hydrogels with a lubricious surface. The patent concerns injecting of nonbiodegradable material which appears by the finding of such material in the brain tissues. Thus any material injected into tissues has a risk of being carried away by the venous blood to central parts of the body. For individuals with a life expectancy of several years this is not likely to be accepted by regulatory authorities. Therefore, such materials are presently not widely used due to migration to critical tissues or long term negative reactions on the health like autoimmune diseases or cancer.
Homotransplantation of tissue is a cumbersome and painful procedure that has a too short action. The most frequently used material today is collagen suspension. However it is made from bovine collagen and can carry unwanted slow action viruses. Most negative is the fact that some patients develop a sensitivity towards the material or get stimulated enzymatic activity in the skin due to repeated foreign body reactions. Despite these drawbacks the products are still very popular. An interesting new product under clinical evaluation is a crosslinked form of hyaluronic acid.
U.S. Pat. No. 5,143,724 teaches the use of viscoelastic gel slurries of high biocompatibility. The patent relates to materials based on hyaluronic acid or s.c. hylans with very low cell interaction which is very useful in some applications but which has a limited value in tissue augmentation uses. The reason is because these materials will spread out in the tissue and loose it's augmenting property.
From the above it appears that the existing materials are clearly not ideal end the search for new improved materials for tissue augmentation continues with the aim to identify materials that are biocompatible, injectable through thin needles, non health threatening and has a residence time in tissues--short enough to disappear when their function is no longer desirable but long enough to be worth the effort to make the implantation.
The present invention addresses this aspect as well as that of versatility in designing an ideal composition for a specific tissue that needs to be augmented. In addition, these same compositions have proven to be very useful vehicles for the delivery of drugs.
SUMMARY OF THE INVENTION
The present invention provides for a composition for tissue augmentation that allows for a rich variety of polymers to be injected through thin or long needles into desired position in the human or animal body. The implanted polymers can be composed to create different configurations in the tissue from very round ball-type forms to flat sheet formed implants. All this for the purpose of providing an optimal cosmetic result or therapeutic effect.
Although these conditions requiring tissue a
REFERENCES:
patent: 4197846 (1980-04-01), Bucalo
patent: 4716154 (1987-12-01), M alson et al.
patent: 4767463 (1988-08-01), Brode et al.
patent: 4777200 (1988-10-01), Dymond et al.
patent: 4803075 (1989-02-01), Wallace
patent: 5007940 (1991-04-01), Berg
patent: 5017229 (1991-05-01), Burns et al.
patent: 5128326 (1992-07-01), Balazs et al.
patent: 5143724 (1992-09-01), Leshchiner et al.
patent: 5399351 (1995-03-01), Leshchiner et al.
"Inflammation Responsive Degradation of Cross-Linked Hyaluronic Acid Gels", Journal of Controlled Release, Nobuhijo Yui et al., 22 (1992), pp. 105-116.
"Cross-Linked Gels of Hyaluronic Acid", Torvard C. Laurent et al., Acta Chem. Scand., No. 1, p. 274, (1964).
Azpuru Carlos A.
Medinvent
LandOfFree
Composition and a method for tissue augmentation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and a method for tissue augmentation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and a method for tissue augmentation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2327235